BIO-CEO Wraps Up 19th Annual Investor Conference

Now in its 19th year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on […]

Read more »

SafeHeal Medical’s Solution to Reshape Digestive Surgery

SafeHeal Medical is a company developing a breakthrough solution for patients undergoing colorectal surgery. Its product, the SafeHeal Colovac device, […]

Read more »

Catalia Health’s Healthcare Robot Improves Patient Outcomes

Catalia Health, a San Francisco-based company, is garnering attention from the medtech industry with its healthcare robot. The “Mabu” is […]

Read more »

Wafergen’s Smartchip Mydesign Genomic Technology to be Employed by Procter & Gamble

Wafergen Biosystems and Procter & Gamble recently announced their industrial partnership that involves the latter utilizing the former’s specialized quantitative […]

Read more »

Cellular Biomedicine Group Joins Force With Huntsworth Health For KOL Advocacy On Clinical Research For Knee Osteoarthritis

Cellular Biomedicine Group, Inc. (CBMG) has took on Hunstworth Health to put in order a team of medical experts for […]

Read more »

Capnia Develop Cluster Headache Medicine with Partner Clinvest

A recently announced Memorandum of Understanding (MOU) between Capnia, Inc. and Clinvest, a Banyan Group, Inc. division, has brought about […]

Read more »

Aeolus Pharma’s AEOL 10150 Declared Orphan Drug for IPF and Lung-ARS

The US FDA recently announced that the experimental drug being developed by Aeolus Pharmaceuticals, Inc. AEOL 10150 has been granted […]

Read more »

Cavendish Global Health Impact Forum

Cavendish Global 500px-Blenheim_Palace_croppeduniquely brings together leading family offices and their foundations seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences. For more information about Cavendish Global email info@onemedmarket,com. Cavendish will be attending OneMedForum in San Francisco and will be available for meetings.

Read more »

Enable’s Innovative Wearable Injector

Enable expects that there will be over 250 biologic wearablebolus candidates for the device within the next 10 years. The device has several unique features, one of the most important being the ability to use product immediately after transfer from a refrigerator. While the technology is pre-FDA, Enable maintains an existing relationship with the organization and expects to be the first company in the country to complete clinicals and receive FDA approval with this type of technology.

Read more »

Health & Biotech Summit in New York Notes CEOs Wanted

According to Gotsch, CEO of Partnership for New York, “New York uniquely produces more innovative medical technology than any other region, but it lags in new company formation.”h&biotech There are dozens of emerging breakthrough technologies in which significant enterprises could be built, but no CEOs to take the lead. These projects are capable of getting the funding and resources necessary to get off the ground, but are desperate for CEOs and entrepreneurs experienced enough to take ideas from the lab into full fruition

Read more »